February 2022 FDA Recall Drug by Morton Grove Pharmaceuticals, Inc.
D-0713-2022 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Morton Grove Pharmaceuticals, Inc. on February 21, 2022 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0713-2022

Reason for Recall
Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.
Initiated
02-21-2022
Reported
03-09-2022
Quantity

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Morton Grove Pharmaceuticals, Inc.
Nationwide USA and Puerto Rico
Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.

Batch or Lot Expiration Information

Lot# s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23